Tony Wood, GSK’s chief scientific officer, said: “We are excited by this new data which shows that a single dose of Arexvy ...

GSK has agreed to pay $2.2bn to settle about 80,000 Zantac lawsuits in the US. In a statement released after the close of ...

The settlement, which is at the low end of Jefferies analysts’ $2 billion to $3.5 billion estimate, will resolve 93% of the ...

RSV vaccines have reportedly fallen since U.S. regulators narrowed the recommended age range and frequency for the shots.

The protection also held across different strains, for people in their 70s, and for those with underlying medical conditions.

GSK’s $2.2 billion Zantac settlement today put its shares top of the FTSE 100, albeit still well short of their level before ...

A study of long-term care facilities found residents with penicillin allergies were 95% less likely to receive beta-lactam ...

Teva Pharmaceutical Industries Ltd. ADR 1.14% $19.77B ...

Bayer (BAYN: DE) has partnered with MOMA Therapeutics to develop a small molecule oncology program using MOMA’s KNOMATIC ...

Russia has made slow but steady gains in recent weeks against Ukraine but at a steep cost — the bloodiest month in the nearly three-year war, U.S. officials said Wednesday. Casualties from the ...

The terrorists took the lives of some Israelis with special needs, and these losses, along with the trauma and dislocations of the war, have caused great suffering in this community. Sen. Lindsey ...

Palestinian photographer Saher Alghora reflects on one year of life and death in Gaza. 'The world is on fire, and I’m not that interested in laundry-folding content,' the 'Succession' actor says ...